These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34461737)

  • 1. Prevalence and Outcomes of p.Val142Ile
    Chandrashekar P; Alhuneafat L; Mannello M; Al-Rashdan L; Kim MM; Dungu J; Alexander K; Masri A
    Circ Genom Precis Med; 2021 Oct; 14(5):e003356. PubMed ID: 34461737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy.
    Mazzarotto F; Argirò A; Zampieri M; Magri C; Giotti I; Boschi B; Frusconi S; Gennarelli M; Buxbaum J; Polimanti R; Olivotto I; Perfetto F; Cappelli F
    Eur J Hum Genet; 2023 May; 31(5):541-547. PubMed ID: 36380086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience.
    Cappelli F; Frusconi S; Bergesio F; Grifoni E; Fabbri A; Giuliani C; Falconi S; Bonifacio S; Perfetto F
    J Cardiovasc Med (Hagerstown); 2016 Feb; 17(2):122-5. PubMed ID: 26428663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First description of Portuguese patients with cardiac amyloidosis and p.Val142Ile: more evidence of an "African variant" in Caucasians.
    da Costa CM; Amador AF; Calvão J; Vasconcelos Porto A; Fernandes S; Martins E; Macedo F
    Scand Cardiovasc J; 2023 Dec; 57(1):2197183. PubMed ID: 37029471
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DISCOVERY: prevalence of transthyretin (
    Akinboboye O; Shah K; Warner AL; Damy T; Taylor HA; Gollob J; Powell C; Karsten V; Vest J; Maurer MS
    Amyloid; 2020 Dec; 27(4):223-230. PubMed ID: 32456532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
    Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
    Parker MM; Damrauer SM; Tcheandjieu C; Erbe D; Aldinc E; Hawkins PN; Gillmore JD; Hull LE; Lynch JA; Joseph J; Ticau S; Flynn-Carroll AO; Deaton AM; Ward LD; Assimes TL; Tsao PS; Chang KM; Rader DJ; Fitzgerald K; Vaishnaw AK; Hinkle G; Nioi P
    Sci Rep; 2021 Jun; 11(1):11645. PubMed ID: 34079032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
    Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
    J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining.
    Abouelhoda M; Mohty D; Alayary I; Meyer BF; Arold ST; Fadel BM; Monies D
    Hum Genomics; 2021 Aug; 15(1):52. PubMed ID: 34380564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
    Madhani A; Sabogal N; Massillon D; Paul LD; Rodriguez C; Fine D; Helmke S; Winburn M; Kurian D; Raiszadeh F; Teruya S; Cohn E; Einstein AJ; Miller EJ; Connors LH; Maurer MS; Ruberg FL
    J Am Heart Assoc; 2023 Aug; 12(15):e028973. PubMed ID: 37486082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
    Lahuerta C; Menao S; Gracia-Gutierrez A; Bueno-Juana E; Guillén N; Sorribas V; Gracia AA; Aibar MA
    Int J Cardiol; 2020 Feb; 301():220-225. PubMed ID: 31740141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
    JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study.
    Albenque G; Bézard M; Kharoubi M; Odouard S; Lunati A; Poullot E; Zaroui A; Teiger E; Hittinger L; Audard V; El Karoui K; Funalot B; Fanen P; Damy T; Oghina S
    Amyloid; 2023 Dec; 30(4):407-415. PubMed ID: 37377439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin Amyloidosis Presenting With Upper-Extremity Neuropathy and Paucity of Autonomic Impairment.
    Devarapalli S; Zhou DJ; Dyck PJB; Piccione EA
    J Clin Neuromuscul Dis; 2019 Jun; 20(4):207-209. PubMed ID: 31135624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
    Agbor-Etang BB; Okafor HE; Farber-Eger EH; Wells QS
    Am J Med; 2021 Feb; 134(2):e98-e100. PubMed ID: 32866461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis.
    Dungu JN; Papadopoulou SA; Wykes K; Mahmood I; Marshall J; Valencia O; Fontana M; Whelan CJ; Gillmore JD; Hawkins PN; Anderson LJ
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27618855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
    Parcha V; Malla G; Irvin MR; Armstrong ND; Judd SE; Lange LA; Maurer MS; Levitan EB; Goyal P; Arora G; Arora P
    JAMA; 2022 Apr; 327(14):1368-1378. PubMed ID: 35377943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy.
    Iino T; Nagao M; Tanaka H; Yoshikawa S; Asakura J; Nishimori M; Shinohara M; Harada A; Watanabe S; Ishida T; Hirata KI; Toh R
    Sci Rep; 2024 Sep; 14(1):20508. PubMed ID: 39227655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.